Pfizer COVID drug Paxlovid is effective with high-risk people: updates

A study found that Pfizer's antiviral drug, Paxlovid, reduced hospitalization or death among high-risk people by 89%. More COVID-19 updates.

Related Keywords

South Africa ,Mauritius ,United States ,Seychelles ,Americans ,America ,South African ,American ,Billie Eilish ,Albert Bourla ,Adrianna Rodriguez ,Davidp Norton ,Karen Weintraub ,Danielle Ivanov ,Mark Cameron ,Ron Desantis ,Matshidiso Moeti ,Celina Tebor ,Gainesville Sun ,Johns Hopkins University ,Office Of Compliance ,World Health Organization ,University Of Florida ,Case Western Reserve University School Of Medicine ,Pfizer ,Stern ,Facebook ,Kroger ,Discovery Health ,University Of Florida Research ,Air Force ,Howard Stern ,North America ,South America ,Case Western Reserve University School ,Florida Research ,Faculty Senate Ad Hoc Committee ,Academic Freedom ,